|
1) |
Kupelian PA, Elshaikh M, Reddy CA, et al. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era:a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol. 2002;20(16):3376-85. |
2) |
Akakura K, Isaka S, Akimoto S, et al. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer:radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology. 1999;54(2):313-8. |
3) |
Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003;57(4):915-28. |
4) |
Hanks GE, Hanlon AL, Pinover WH, et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 1999;5(3):152-8. |
5) |
Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response:an update of the fox chase experience. J Urol. 2004;171(3):1132-6. |
6) |
Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response:results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53(5):1097-105. |
7) |
Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166(3):876-81. |
8) |
Vicini FA, Abner A, Baglan KL, et al. Defining a dose-response relationship with radiotherapy for prostate cancer:is more really better? Int J Radiat Oncol Biol Phys. 2001;51(5):1200-8. |